Medtronic Plc (0Y6X.L) LSE
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Medtronic Plc
Sector
Healthcare
Industry
Medical - Devices
Employees
95000
First IPO Date
March 06, 2017
Key Executives
| Name | Title | Pay | Year Born |
| Geoffrey Straub Martha | Chairman of the Board & Chief Executive Officer | 4.09M | 1970 |
| Kweli Thompson | Executive Vice President & President of Neuroscience Portfolio | 1.86M | 1968 |
| Brett A. Wall | Executive Officer | 2M | 1966 |
| Michelle Quinn | Executive Vice President, General Counsel & Secretary | 2.49M | 1969 |
| Thierry Pieton | Executive Vice President & Chief Financial Officer | 4.22M | 1970 |
| Dave Moeller | Senior VP & President of the Peripheral Vascular Health Operating Unit | 0 | N/A |
| Austin L. Chiang | Chief Medical Officer Gastrointestinal Business | 0 | N/A |
| Alan Cheng | Chief Medical Officer of Cardiac Rhythm Management | 0 | N/A |
| Robert Adam Hopkins | Senior Vice President & Head of Global Strategy | 0 | 1968 |
| Robert Kowal | VP & GM of Cardiac Pacing Therapies | 0 | N/A |
| Denise L. Blomquist | Vice President, Global Controller & Chief Accounting Officer | 0 | N/A |
| Linnea Burman | Senior VP and President of Medtronic's Neurovascular business | 0 | N/A |
| Sally Saba | Chief Inclusion & Diversity Officer | 0 | N/A |
| Matthew Walter | Senior Vice President of Human Resources, IT and Global Communications & Corporate Marketing | 0 | 1979 |
| Jason Weidman | Senior VP and President of Coronary & Renal Denervation business | 0 | N/A |
| Ingrid Goldberg | Vice President & Head of Investor Relations | 0 | N/A |
| Rogerio Branco | SVP & Chief Operations and Supply Chain Officer | 0 | N/A |
| Laura Mauri | Senior Vice President and Chief Scientific & Medical Officer | 0 | 1970 |
Description
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.
